Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY: ELAN )

10.31 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Elanco Animal Health: Q2 Earnings Insights
Shares of Elanco Animal Health (NYSE:ELAN) rose 0.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 211.11% over... 
Via Benzinga
Elanco Animal Health Reports Second Quarter 2021 Results
From Elanco Animal Health Incorporated
Via Business Wire
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... 
Via Benzinga
Analyzing Elanco Animal Health's Unusual Options Activity
Elanco Animal Health (NYSE:ELAN) shares experienced unusual options activity on Tuesday. The stock price moved up to $35.29 following the option alert. Sentiment: BULLISH Option... 
Via Benzinga
This Acquisition Could Open a Whole New Market to Elanco
The pet health company buys yet another business in an effort to fast-track growth and expand its offerings. 
Via The Motley Fool
Elanco Confirms Date and Conference Call for Second Quarter 2021 Financial Results Announcement
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Foundation Announces Partnership with the JBS Fund
From Elanco Animal Health Incorporated
Via Business Wire
Stock Market Rally Shifts To Tech After Fed Meeting; Adobe, Ford In Focus: Weekly Review
Techs seized stock market leadership, despite the Fed signaling earlier rate hikes. But many real economy names dived. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Economy Fossil Fuels Interest Rates
Why Kindred Biosciences Stock Skyrocketed Today
The pet therapeutics pioneer is being scooped up by a global animal health leader. 
Via The Motley Fool
Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today
Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT)... 
Via Benzinga
Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge
Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P also fell, dropping 0.05% to 4,244.41. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Elanco Is Looking To Challenge Zoetis, Will The $440 Million Kindred Buyout Help?
Elanco Animal Health said Wednesday it would buy Kindred Biosciences for roughly $440 million, sending KIN stock soaring. 
Via Investor's Business Daily
Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences
Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&P also fell, dropping 0.01% to 4,246.07. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal
Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to acquire Kindred Biosciences Inc (NASDAQ: KIN) for $9.25 per share, or approximately $440 million... 
Via Benzinga
Elanco Announces Agreement to Acquire Kindred Biosciences
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Animal Health's Debt Overview
Over the past three months, shares of Elanco Animal Health (NYSE:ELAN) rose by 14.38%. Before we understand the importance of debt, let us look at how much debt Elanco... 
Via Benzinga
Elanco Releases Environmental, Social and Governance (ESG) Summary
From Elanco Animal Health Incorporated
Via Business Wire
Elanco To Exit Three Manufacturing Sites To Streamline Footprint
Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to sell its sites in Shawnee, Kansas, and Speke,... 
Via Benzinga
Elanco Announces Exit of Three Manufacturing Sites, Streamlining Footprint
From Elanco Animal Health Incorporated
Via Business Wire
Elanco Announces Addition of Marcela A. Kirberger as General Counsel and Corporate Secretary
From Elanco Animal Health Incorporated
Via Business Wire
Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights
Via FinancialNewsMedia
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Elanco to Participate in Upcoming Investor Conferences
From Elanco Animal Health Incorporated
Via Business Wire
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and... 
Via Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
Elanco Launches Product for U.S. Poultry Producers, Providing a Flexible Option for Cocci Control
From Elanco Animal Health Incorporated
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.